Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

Bhavika K. Patel,Talal Hilal,Matthew F. Covington,Nan Zhang,Heidi E. Kosiorek,Marc Lobbes,Donald W. Northfelt,Barbara A. Pockaj

Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

2018

Bhavika K. Patel
Talal Hilal
Matthew F. Covington
Nan Zhang
Heidi E. Kosiorek
Marc Lobbes
Donald W. Northfelt
Barbara A. Pockaj

Purpose To evaluate the performance of contrast-enhanced spectral mammography (CESM) compared to MRI in the assessment of tumor response in breast cancer patients undergoing neoadjuvant systemic therapy (NST).

Keywords:

Mammography
Breast cancer
Pathology
Radiology
Systemic therapy
Contrast enhanced spectral mammography
Medicine
Surgical oncology
Digital mammography
Malignancy
Nuclear medicine
Surgical pathology
Concordance
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations